Genetic Testing, Insurance Economics, and Societal Responsibility
From MaRDI portal
Publication:5718331
Recommendations
Cited in
(12)- Genetics, Alzheimer’s Disease, and Long-Term Care Insurance
- Optimal risk classification with an application to substandard annuities
- A simulation study for multifactorial genetic disorders to quantify the impact of polygenic risk scores on critical illness insurance
- Genetics and Insurance: What have we Learned So Far?
- Effective Underwriting in the Genetic Testing Era
- Ethical Issues Resulting from Genetic Technology
- Federal Regulation of Use of Genetic Information by Insurers
- Restricting Insurers’ Use of Genetic Information
- Social Implications of Genetic Testing
- The Future of Risk Classification in the Age of Predictive DNA-Based Testing
- The Current State of Genetic Testing
- What Does Genetic Technology Have to Do with Ethics?
This page was built for publication: Genetic Testing, Insurance Economics, and Societal Responsibility
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5718331)